ID (Author year) | Disease | Setting (in/out patients) | Diagnosis criteria | Sample size | Age-T | Age-C | Men-% | Course of treatment |
---|---|---|---|---|---|---|---|---|
Bai LQ 2013 | HF | in | NYHA | 40 | 45 ± 3.7 | 52 ± 4.2 | 57.5 | 3M |
Cai RF 2013 | CHF | NA | CMA 2009; MoH 2002; Framingham criteria; NYHA | 50 | 52-80 | 52-81 | 54 | 4W |
Cai YP 2013 | CHF | in or out | Framingham criteria; NYHA | 108 | 73.2 ± 11.5 | 60.19 | 6M | |
Chen L 2009 | CHF | in | ACC/AHA 1995; MoH 2002; NYHA | 61 | 67.2 ± 11.5 | 63.1 ± 13.8 | 57.38 | 4W |
Chen TC 2013 | CHF | NA | CMA 2007; NYHA | 52 | 71-92 | 68-91 | 53.85 | 4W |
Chen WQ 2012 | CHF | in or out | CMA 2007; NYHA | 120 | 58 ± 14 | 57 ± 14 | 59.17 | 6M |
Chen XH 2014 | HF | NA | CMA 2014 | 60 | 63 ± 10 | 62 ± 11 | 52.17 | 6M |
Cheng XD 2013 | ischemic heart failure | in | ACC/AHA criteria; NYHA | 90 | 56.4 ± 6.2 | 54.2 ± 5.9 | 55.56 | 6W |
Cui LL 2012 | CHF | in | CMA 2007; NYHA | 68 | 59.41 ± 9.68 | 58.6 ± 7.71 | 48.53 | 5M |
Dai JX 2013 | chronic congestive heart failure | NA | Guidelines for the Diagnosis and Treatment of Cardiovascular Disease 2006 | 100 | 70.2 | 58 | 4W | |
Ding LB 2010 | HF | in | Internal Medicine 2004; MoH 2002 | 43 | 45 ± 12.2 | 42 ± 11.3 | 55.81 | 2M |
Ding SY 2013 | CHF | NA | Practical Internal Medicine 2001; NYHA | 72 | 48-82 | 51-79 | 45.83 | 4W |
Dong MX 2013 | chronic congestive heart failure | in | Practical Internal Medicine 2001; NYHA | 114 | 71.5 | 59.65 | 4W | |
Du YK 2014 | diastolic heart failure | out | CMA 2007 | 102 | 60-86 | 59-82 | 39.22 | 30D |
Duan JH 2010 | CHF | NA | Clinical Cardiology 1996 | 61 | 63.4 ± 10.3 | 61.5 ± 8.7 | 72.13 | 3M |
Fan J 2013a | CHF | NA | Internal Medicine 2008; NYHA | 86 | 68.1 ± 9.5 | 68.7 ± 9.6 | 55.81 | 2M |
Feng QT 2013 | chronic congestive heart failure | out | Framingham criteria | 42 | 55.6 ± 10.32 | 54.66 ± 10.41 | 59.52 | 6M |
Fu JZ 2012 | CHF | Internal Medicine 2004; NYHA | 60 | 77.3 ± 10.2 | 78.0 ± 10.1 | 58.33 | 3M | |
Gao JB 2011 | chronic congestive heart failure | in or out | MoH 2002 | 167 | 58 ± 11 | 58.08 | 4W | |
Gu XM 2009 | CHF | in or out | AHA criteria | 38 | 52 ± 9 | 48 ± 10.6 | 68.42 | 2M |
Gu XM 2013 | CHF | in or out | ACC/AHA 2005; NYHA | 65 | 57 ± 18.5 | 56 ± 16 | 66.15 | 4W |
Gu YY 2012 | CHF | in or out | NYHA | 100 | 65.5 ± 10.1 | 62.3 ± 12.5 | 58.57 | 6M |
Guan SY 2012 | CHF | NA | Consensus for diagnosis and treatment of heart failure with normal ejection fraction in China 2010 | 82 | 56 ± 13 | 54 ± 13 | 42.68 | 8W |
Guan SY 2013 | CHF | NA | CMA 2007 | 72 | 55 ± 12 | 54 ± 13 | 52.78 | 12W |
Guo P 2014 | CHF | NA | ACC/AHA criteria; NYHA | 90 | 71.6 ± 4.5 | 72 ± 3.5 | 58.7 | 3M |
Guo SL 2011 | chronic congestive heart failure | in | CMA 2007 | 120 | 60-80 | 60 | 3M | |
Guo WB 2013 | chronic congestive heart failure | in | CHF criteria 1979 | 70 | 61.5 ± 9.12 | 57.4 ± 8.97 | 57.14 | 8W |
Hu B 2013 | CHF | in or out | Framingham criteria | 80 | 39-75 | 36-76 | 78.75 | 3M |
Huang B 2010 | chronic congestive heart failure | NA | Framingham criteria; NYHA | 100 | 61.2 ± 11.8 | 60.8 ± 12.5 | 60 | 6M |
Huang YQ 2012 | chronic congestive heart failure | NA | Internal Medicine 2004 | 46 | 60 ± 7.5 | 58 ± 7.8 | 47.83 | 4W |
Huang Z 2014 | CHF | in or out | CMA 2007; NYHA | 60 | 35-74 | 35-74 | 58.33 | 12W |
Jin Y 2012 | heart failure derived from ischemic cardiomyopathy | NA | ICM criteria (Felker GM) 2002; NYHA | 100 | 62.0 ± 15.2 | 63.0 ± 13.9 | 47 | 12W |
Jing GJ 2009 | CHF | in or out | WHO criteria; CMA 2002; MoH 2002 | 60 | 62.0 ± 3.5 | 63 ± 4.0 | 58.33 | 4W |
Kuang JB 2008 | CHF | NA | ESC criteria | 106 | 71.6 | 45.16 | 8W | |
Li DW 2013 | chronic congestive heart failure | in | NYHA | 78 | 66 | 51.28 | 12W | |
Li GM 2011 | chronic congestive heart failure | in or out | Framingham criteria; NYHA | 120 | 72.5 | 71.8 | 56.67 | 4W |
Li LC 2013 | heart failure derived from ischemic cardiomyopathy | NA | NYHA | 110 | 61 ± 13 | 63 ± 12 | 54.55 | 4W |
Li P 2011 | CHF | in or out | CMA 2002;NYHA | 76 | 66.1 ± 7.8 | 66.3 ± 7.2 | 59.21 | 3M |
Li Q 2014 | HF | NA | NYHA | 120 | 71.4 ± 8.0 | 70.2 ± 7.1 | 70.59 | 6M |
Li RY 2010a | CHF | NA | NYHA | 86 | 68.4 ± 1.3 | 68.1 ± 1.3 | 67.44 | 4W |
Li SQ 2014 | CHF | in or out | CMA 2007; NYHA | 147 | 41.2 ± 12.5 | 39.8 ± 13.2 | 40.82 | 2M |
Li SZ 2009 | congestive heart failure | NA | NYHA | 39 | 62 ± 7 | 56.41 | 4W | |
Li T 2010 | CHF | in | Boston criteria; NYHA | 44 | 56 ± 14 | 56.82 | 4W | |
Li WY 2013 | CHF | NA | Internal Medicine 2008; NYHA | 90 | 71 ± 4.6 | 73 ± 4.2 | 57.78 | 4W |
Li XL 2013 | CHF | NA | CMA 2007; NYHA | 512 | 56.98 ± 11.59 | 57.53 ± 11.05 | 75.36 | 12W |
Li YH 2013 | CHF | NA | NYHA | 80 | 67.3 ± 11.6 | 70 | 3M | |
Li YX 2012 | diastolic heart failure | in or out | ESC criteria; MoH 2002 | 100 | 61.6 ± 5.1 | 61.4 ± 5.4 | 43 | 6M |
Li YX 2013 | CHF | NA | ESC 2007; MoH 2002;Collateral Disease Theory 2006 | 80 | 61.6 ± 5.1 | 61.4 ± 5.4 | 46.25 | 12M |
Lin JH 2008 | CHF | in or out | Clinical Cardiology 1999; NYHA | 80 | 58 ± 12 | 60 | 4W | |
Lin ZJ 2010 | heart failure derived from ischemic cardiomyopathy | NA | WHO/ISFC 1980; NYHA | 60 | 40 ± 13 | 38 ± 12 | 45 | 6M |
Liu HL 2008 | CHF | NA | Guidelines for Cardiovascular Disease 2005; NYHA | 86 | 32.9 ± 4.1 | 33.1 ± 3.2 | 52.33 | 4W |
Liu J 2008 | heart failure derived from ischemic cardiomyopathy | NA | WHO/ISFC 1980; NYHA | 41 | 41 ± 11 | 40 ± 11 | 60.98 | 6M |
Liu LX 2014 | HF | NA | Practical Internal Medicine 2009 | 60 | 64.4 ± 11.5 | 64.5 ± 11.3 | 61.67 | 12W |
Liu SJ 2009 | CHF | in or out | Clinical Cardiology 1996; MoH 2002; NYHA | 45 | 68.2 ± 7.6 | 66.8 ± 8.2 | 60 | 4W |
Liu T 2013 | HF | NA | NYHA | 95 | 63.7 ± 7.4 | 65.7 ± 7.6 | 71.58 | 4W |
Liu TR 2010 | CHF | NA | NYHA | 84 | 46-68 | 45-70 | 63.1 | 8W |
Liu WJ 2007 | ischemic cardiomyopathy | in | Felker's criteria | 60 | 66 ± 10 | 65 ± 11 | 70 | 4M |
Liu XC 2008 | refractory heart failure | NA | NYHA | 120 | 56-79 | 58-78 | 80.83 | 30D |
Liu XC 2011 | CHF | in or out | AHA criteria; NYHA | 80 | 56.9 ± 7.3 | 57.0 ± 7.6 | 65 | 8W |
Liu XG 2013 | CHF | in or out | AHA criteria; NYHA; MoH 2002 | 60 | 61.2 ± 11.8 | 60.8 ± 12.5 | 58.33 | 3M |
Liu XM 2010 | HF | NA | ACC/AHA criteria; NYHA | 76 | 65-82 | 52.63 | 3M | |
Liu XM 2013 | CHF | NA | CMA 2007 | 64 | 69 ± 11 | 68 ± 12 | 57.81 | 4W |
Liu YJ 2012 | HF | in or out | Clinical Cardiology; NYHA | 60 | 78-90 | 76-92 | 68.33 | 30D |
Long F 2009 | CHF | in | Clinical Cardiology 1996; CMA 2002; NYHA | 110 | 20-73 | 18-70 | 53.64 | 4W |
Lu JP 2012 | CHF | in | CMA 2007; NYHA | 60 | 73.2 ± 12.5 | 72.9 ± 11.8 | 65 | 24W |
Luo Q 2013 | chronic congestive heart failure | in | NYHA | 60 | 62.5 ± 13.0 | 64.5 ± 12.2 | 56.67 | 3M |
Ma AP 2013 | CHF | NA | NYHA | 96 | 66.28 ± 4.92 | 65.84 ± 5.06 | 56.25 | 6M |
Ma FF 2008a | CHF | in | Boston criteria 1985; NYHA | 120 | 65.4 | 64.6 | 46.67 | 4W |
Ma FF 2008b | CHF | in | Boston criteria 1985; NYHA | 65 | 64.1 ± 17.2 | 46.15 | 4W | |
Ma L 2010 | CHF | in or out | ESC 1995; NYHA; MoH 2002 | 117 | 52.3 ± 9.2 | 50.1 ± 10.5 | 61.54 | 4W |
Ma RX 2014 | CHF | in | CMA 2007 | 120 | 62 ± 12 | 60 ± 11 | 65.75 | 4W |
Miao S 2013 | HF | NA | NYHA | 102 | 77.2 ± 6.1 | 100 | 2M | |
Niu LY 2012 | CHF | NA | ACC/AHA criteria; NYHA; MoH 2002 | 60 | 63.2 ± 4.1 | 60.8 ± 5.4 | 63.33 | 4W |
Pang XM 2008 | CHF | NA | Framingham criteria | 31 | 66 ± 12 | 48.39 | 4W | |
Qiu X 2013 | CHF | NA | NYHA | 60 | 62 ± 4.2 | 60 ± 3.2 | 66.67 | 3M |
Rao LZ 2012 | CHF | NA | CMA 2007; NYHA | 80 | 65 ± 15 | 64 ± 14 | 51.25 | 4W |
Shen R 2010 | HF | in | NYHA | 62 | 74 ± 5 | 74 ± 7 | 77.42 | 28D |
Shen XR 2014 | CHF | in or out | ACC/AHA criteria; NYHA | 122 | 62 ± 6 | 66.45 | 12M | |
Shi CP 2013 | CHF | in | ISFC/WHO 1979; NYHA | 120 | 64.5 ± 6.2 | 67.5 | 3M | |
Su HM 2007 | chronic congestive heart failure | in | Framingham criteria; NYHA 1994 | 70 | 55.7 | 54.6 | 60 | 30D |
Su LJ 2012 | CHF | in or out | CMA 2002; Practical Internal Medicine 2001; NYHA | 69 | NA | NA | 65.22 | 8W |
Su RY 2013 | CHF | NA | CMA 2007; NYHA | 86 | 69 | 46.51 | 4W | |
Sun LP 2007 | chronic congestive heart failure | in | NYHA | 60 | 62 ± 12 | 63.33 | 12W | |
Tang SY 2013 | CHF | in | CMA 2002; Clinical Cardiology 1996; Internal Medicine 2004; NYHA | 80 | 65.4 | 64.6 | 47.5 | 4W |
Tao X 2011 | CHF | NA | ESC 2008 | 100 | NA | NA | 0 | 4W |
Tian Y 2011 | diastolic heart failure | NA | ESC criteria; MoH 2002 | 100 | 58.0 ± 8.2 | 58.0 ± 8.5 | 47 | 1M |
Wang N 2014 | CHF | in or out | MoH 2002 | 54 | 55-75 | 58-76 | 53.7 | 8W |
Wang Q 2012 | CHF | in or out | NYHA | 80 | 40-70 | 41-70 | 61.25 | 24W |
Wang SZ 2012 | HF | NA | Diabetic Cardiomyopathy 2010; NYHA | 60 | 60 ± 13 | 60 ± 11 | 61.67 | 4W |
Wang YY 2013 | chronic congestive heart failure | in or out | NYHA | 79 | 62.6 ± 2.4 | 61.4 ± 2.3 | 53.16 | 4W |
Wei XB 2013 | CHF | in | NYHA; ACC/AHA 2009 | 84 | 87 ± 6 | 100 | 12W | |
Wen Y 2012 | CHF | NA | CMA 2007; NYHA | 90 | 70.4 ± 5.6 | 57.78 | 1M | |
Wu GL 2015 | CHF | out | CMA 2007; NYHA | 104 | 67.5 ± 6.8 | 66.7 ± 7.1 | 64.32 | 2M |
Wu SP 2014 | CHF | in or out | CMA 2014 | 130 | 52.2 ± 5.8 | 53.8 ± 7.3 | 73.8 | 4W |
Wu Xian 2014 | CHF | in | CMA 2007 | 60 | 64.47 ± 8.23 | 63.57 ± 8.94 | 55.38 | 4W |
Xiong SQ 2014 | CHF | in | CMA 2007; NYHA | 80 | 61.2 ± 7.11 | 62.3 ± 7.45 | 52.5 | 6W |
Xu GS 2014 | CHF | NA | NYHA | 64 | 55.7 ± 14.0 | 53.6 ± 15.0 | 59.38 | 120D |
Xue L 2014 | CHF | in | A list of clinical manifestation | 124 | 42-86 | 64.52 | 8W | |
Xue LX 2008 | chronic congestive heart failure | in or out | AHA criteria | 80 | 56.9 ± 7.3 | 57.0 ± 7.6 | 65 | 8W |
Yan KL 2012 | CHF | in | Practical Internal Medicine 2009; NYHA | 120 | 65.2 ± 17.5 | 56.67 | 12W | |
Yang DK 2014 | CHF | in | NYHA | 60 | 66.0 ± 12.06 | 65.8 ± 11.33 | 63.33 | 4W |
Yang F 2007 | CHF | NA | ESC 2005 | 128 | 66.0 ± 14.0 | 65.0 ± 15.0 | 56.25 | 8W |
Yang HT 2012 | CHF | in | Clinical Cardiology 1999; NYHA | 100 | 58.5 ± 7.0 | 59 ± 7.6 | 57 | 4W |
Yang HT 2013 | CHF | in | Clinical Cardiology 1999 | 100 | 58.5 ± 7.0 | 59 ± 7.6 | 57 | 4W |
Yang J 2013 | CHF | NA | CMA 2007; NYHA | 90 | 56.8 ± 4.3 | C1 (57.2 ± 4.1) C2 (57.1 ± 3.9) | 43.33 | 12W |
Yang W 2012 | CHF | in | CMA 2007; NYHA | 80 | 60.52 ± 12.6 | 62.7 ± 9.6 | 56.25 | 4W |
Yao L 2011 | CHF | in | CMA 2007; NYHA | 102 | 52 ± 11 | 56 ± 9 | 52.94 | 8W |
Ye RS 2013 | CHF | NA | CMA 2007; NYHA | 80 | 65-92 | 65-90 | 56.25 | 6M |
Ye S 2012 | CHF | in | CMA 2007; NYHA | 114 | 60.29 ± 5.62 | 53.51 | 3M | |
Yin ZL 2009 | congestive heart failure | in | Framingham criteria; NYHA | 50 | 57.4 ± 7.6 | 66 | 4W | |
Ying M 2013 | CHF | NA | Framingham criteria; NYHA | 80 | 50-80 | 52.5 | 3M | |
Yu JH 2008 | diastolic heart failure | in | Framingham criteria; CHFA 2001; NYHA | 70 | 65.7 ± 6.1 | 66.1 ± 8.2 | 60 | 12M |
Yuan JK 2012 | HF | in | NYHA | 62 | 41.65 ± 9.33 | 43.08 ± 7.55 | 58.06 | 4W |
Zhai N 2015 | CHF | NA | CMA 2014 | 80 | 70.6 ± 4.4 | 61.54 | 12W | |
Zhang CA 2013 | CHF | in or out | AHA 1995; NYHA | 83 | 59.31 ± 10.19 | 61.0 ± 8.39 | 66.27 | 12W |
Zhang H 2011 | CHF | NA | ISFC/WHO criteria | 123 | 45-80 | 50-82 | 60.16 | 4W |
Zhang J 2015 | CHF | NA | Practical Internal Medicine 1998,NYHA | 60 | 63.1 ± 9.5 | 62.5 ± 8.2 | 50 | 4W |
Zhang R 2014 | CHF | in | CMA 2007; NYHA | 80 | 55.0 ± 10.9 | 53.0 ± 11.3 | 62.14 | 8W |
Zhang WL 2013 | CHF | in | NYHA | 94 | 47-86 | 45-87 | 58.51 | 4W |
Zhang XX 2010 | left cardiac insufficiency | NA | NYHA | 136 | 53.5 | 52.94 | 6M | |
Zhao JS 2014 | CHF | NA | CMA 2007; NYHA; MoH 2002 | 450 | 54.8 ± 4.6 | 55.3 ± 4.7 | 48.33 | 12W |
Zhao MJ 2009 &Zhao MJ 2012 | HF | in or out | Framingham criteria; NYHA | 68 | 46-69 | 45-69 | 64.71 | 4W |
Zheng JJ 2012 | CHF | in | CMA 2007; NYHA | 76 | 64 ± 15 | 64 ± 14 | 55.26 | 6M |
Zheng LW 2013 | CHF | in or out | CMA 2007; NYHA | 164 | 66.9 ± 11.5 | 67.8 ± 12.0 | 53.05 | 12W |
Zheng WH 2014 | refractory heart failure | NA | NYHA | 87 | 63.44 ± 2.20 | 61.92 ± 2.70 | 56.32 | 6W |
Zhou FZ 2011a | congestive heart failure | in | NYHA | 59 | 66 | 69.49 | 12W | |
Zhou Y 2013 | HF | NA | Internal Medicine 2010 | 60 | 56.9 ± 7.3 | 57.0 ± 7.6 | 63.33 | 8W |
Zhu HG 2012 | CHF | in or out | NYHA | 78 | 63.1 | 63.4 | 61.54 | 3M |
Zhuo JY 2013 | CHF | NA | NYHA | 136 | 62.74 ± 7.78 | 61.01 ± 8.12 | 54.41 | 4W |